Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease

ClinicalTrials.gov ID: NCT02079246

Public ClinicalTrials.gov record NCT02079246. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 1:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the long-term safety and tolerability of idalopirdine (Lu AE58054) as adjunctive therapy to donepezil in patients with mild-moderate Alzheimer's Disease (AD).

Study identification

NCT ID
NCT02079246
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
H. Lundbeck A/S
Industry
Enrollment
1,463 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 7, 2014 (Actual)
Primary completion
Jul 6, 2017 (Actual)
Completion
Jul 6, 2017 (Actual)
Last update posted
Aug 10, 2018

2014 – 2017

United States locations

U.S. sites
64
U.S. states
27
U.S. cities
59
Facility City State ZIP Site status
US027 Birmingham Alabama — —
US012 Phoenix Arizona — —
US338 Phoenix Arizona — —
US024 Little Rock Arkansas — —
US351 Carlsbad California — —
US346 Costa Mesa California — —
US327 Fullerton California — —
US023 Imperial California — —
US045 Long Beach California — —
US307 Redlands California — —
US058 San Francisco California — —
US018 Santa Ana California — —
US301 Santa Rosa California — —
US021 Bradenton Florida — —
US050 Brooksville Florida — —
US308 Delray Beach Florida — —
US320 Hallandale Florida — —
US347 Hialeah Florida — —
US340 Lake Worth Florida — —
US303 Miami Florida — —
US313 Miami Florida — —
US345 Orange City Florida — —
US019 Orlando Florida — —
US309 Palm Beach Gardens Florida — —
US038 Port Charlotte Florida — —
US302 Sunrise Florida — —
US304 Atlanta Georgia — —
US360 Augusta Georgia — —
US048 Kailua Hawaii — —
US030 Chicago Illinois — —
US040 Indianapolis Indiana — —
US334 Lake Charles Louisiana — —
US036 Freeport Maine — —
US344 Boston Massachusetts — —
US035 Kalamazoo Michigan — —
US310 Saint Paul Minnesota — —
US041 Flowood Mississippi — —
US321 Hattiesburg Mississippi — —
US339 Paterson New Jersey — —
US046 Princeton New Jersey — —
US028 Toms River New Jersey — —
US044 Toms River New Jersey — —
US014 Manhasset New York 11030 —
US029 New York New York — —
US312 Staten Island New York — —
US316 Charlotte North Carolina — —
US336 Winston-Salem North Carolina — —
US007 Centerville Ohio — —
US323 Cincinnati Ohio — —
US006 Columbus Ohio — —
US306 Columbus Ohio — —
US352 Lakewood Ohio — —
US333 Oklahoma City Oklahoma — —
US026 Portland Oregon — —
US057 Jenkintown Pennsylvania — —
US324 Pittsburgh Pennsylvania — —
US341 Pittsburgh Pennsylvania — —
US319 Port Royal South Carolina — —
US356 Cordova Tennessee — —
US343 Fort Worth Texas — —
US354 Houston Texas — —
US047 Arlington Virginia — —
US025 Madison Wisconsin — —
US004 Milwaukee Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 194 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02079246, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 10, 2018 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02079246 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →